Paul Szabolcs MD
Professor, Pediatrics, Immunology, University of Pittsburgh School of Medicine
Join to View Full Profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-620-5042
Dr. Szabolcs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1990 - 1993
NYU Grossman School of MedicineResidency, Pediatrics, 1987 - 1990
Semmelweis UniversityClass of 1985
Certifications & Licensure
PA State Medical License 2011 - 2026
NC State Medical License 1998 - 2012
Awards, Honors, & Recognition
- Lisa Stafford Memorial Research Prize Duke University Comprehensive Cancer Center, 2000
- Best Student of the Year Pecs University of Medical Sciences, 1990
- 1st Prize for Critical Thesis Pecs University of Medical Sciences, 1980
Clinical Trials
- Autologous Stem Cell Transplantation for Crohn's Disease Start of enrollment: 2012 Jun 26
- Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases Start of enrollment: 2013 Jun 20
- Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT Start of enrollment: 2014 Feb 04
Publications & Presentations
PubMed
- Durable hematopoiesis and tolerance after vertebral bone marrow transplant from a deceased lung transplant donor.Paul Szabolcs, Xiaohua Chen, Marian G Michaels, Memphis Hill, Evelyn Garchar
JCI Insight. 2026-03-23 - 2 citationsDelayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults.Miguel-Angel Perales, Marcie Riches, Naya He, Michael J Martens, Roy F Chemaly
Blood Advances. 2025-07-22 - Prophylactic high-dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation.Yannis Hadjiyannis, Robert Bubar, Darrell J Triulzi, Joseph Kiss, Christopher C Marino
Vox Sanguinis. 2025-05-14
Journal Articles
- Tolerance After Lung and Bone Marrow Transplantation from an Unrelated Cadaveric DonorBuckley R, Davis R, Moffet J, Voynow J, Jeyaraj A, Chen X, Sempowski G, Zaas D, Journal of Allergy and Clinical Immunology, 1/1/2015
- IL-7 permits Th1/Tc1 maturation of cord blood T cells while enhances ex vivo expansion in collaboration with CD3/CD28 costimulatory beads and Il-2: A critical step tow...Davis CC, Marti L, Sempowski G, Jeyaraj DA, Cancer Research, 1/1/2010
- Superior depletion of alloreactive T cells from PBSC and umbilical cord blood grafts by the combined use of trimetrexate and IL-2 immunotoxinPark KD, Marti L, DeOliveira D, Lee Y, Colvin MO, Kurtzberg J, Biology of Blood and Marrow Transplantation, 1/1/2004
Press Mentions
- Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health EquityApril 25th, 2022
- Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual MeetingDecember 11th, 2021
- Rockton Man Gets Approved for Extremely Rare, Life Saving SurgeryJuly 8th, 2021
Grant Support
- CADAVERIC DONOR LUNG AND BONE MARROW TRANSPLANTATION IN IMMUNODEFICIENCY DISEASESNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES2016–2021
- Graft Engineering And Immunotherapy After Unrelated Cord Blood TransplantationNational Cancer Institute2011
- Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2009–2011
- Graft Engineering And Immunotherapy After Unrelated Cord Blood TransplantationNational Cancer Institute2007–2010
- Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2008
Professional Memberships
- Member
- Member
Other Languages
- Hungarian
External Links
- Pitt Immunologyhttp://www.immunology.pitt.edu/person/paul-szabolcs-md
- Center for Rare Diseases Therapyhttp://www.chp.edu/our-services/rare-disease-therapy/doctors-and-staff/paul-szabolcs
- Division of BMT&CThttp://www.chp.edu/our-services/blood-marrow-transplant-cellular-therapies
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
